Star Lake Bioscience: Major shareholder trims stake, crosses regulatory threshold

Star Lake Bioscience Inc Zhaoqing Guangdong announced on October 24, 2025, that its major shareholder, Tie Xiaorong, and her concerted party, Ningxia Yipin Investment Group Co., Ltd., reduced their collective stake in the company. This equity change, which occurred on October 23, 2025, saw the total shareholding decrease from 12.76% to 11.61%, crossing the 1% equity change threshold.

The reduction involved Tie Xiaorong divesting 19,120,000 shares through a combination of centralized bidding and block trading. Prior to the change, Tie Xiaorong held 39,306,201 shares, representing 2.37% of the company. After the transaction, her holdings decreased to 20,186,201 shares, or 1.21%. Ningxia Yipin Investment Group’s holdings remained unchanged at 172,685,029 shares, representing 10.39%.

The company confirmed that this equity change does not trigger a mandatory tender offer, nor will it alter the company's controlling shareholder or actual controller. Furthermore, it is not expected to impact the company's corporate governance structure or ongoing operations.